drugset / Trial / NCT02065167
Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip
NaSingle-groupOpen-labelTreatment
Summary
The purpose is to assess the safety and feasibility of cellular therapy derived from bone marrow, to help bone healing in patients with avascular necrosis of the hip.
Timeline
- Start
- 2014-02
- Primary completion
- 2016-06
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cultured autologous Mesenchymal Cells | Cell therapy | 1.4e+08 cells | Other |